Choline Bitartrate
Choline Bitartrate is used in private-label supplement manufacturing. Sourcing, dose anchors and target-market documentation are reviewed per project.
- Type
- Vitamin
- Family
- B-vitamins
- Measured in
- mg
At a glance
- Format suitability
- Reviewed for gummies — confirmed per project.
Why brands use Choline Bitartrate
Choline Bitartrate is an essential vitamin commonly considered for daily-wellness ranges, sitting in the b-vitamins family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only applicable claims framework- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Choline Bitartrate for gummies; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — we don’t publish off-the-shelf doses.
How we use Choline Bitartrate in formulas
A public-safe formulation reference — how this active behaves in our formats, common pairings and handling notes. Final formulation, dose and on-pack copy are confirmed per project.
- Heat stable
- Limited — use coated forms
- Soluble in matrix
- Conditional
- Vegan supply
- Project-specific
US structure-function statements
Structure-function wording for this ingredient is reviewed per project against DSHEA (21 USC §343(r)(6)). No final on-pack copy is implied by this page.
Across the EU and UK markets Choline Bitartrate is treated as a vitamin: any on-pack benefit wording must come from the applicable claims framework register (UK retains the same wording post-Brexit), and the inclusion rate has to meet the minimum thresholds tied to the chosen claim. For the US market, label benefit copy follows DSHEA structure-function rules with the standard "not intended to diagnose, treat, cure or prevent any disease" disclosure. We never reuse a market’s wording as if it carried over — claim copy is rewritten per market and reviewed per project. Country-level rules (e.g. France, Italy, Belgium for the EU; California Prop 65 for the US) layer on top, and the back-of-pack nutritional table is built against the market’s reference intake framework.
Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
